N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal inflammation and tubulointerstitial fibrosis in rats

International Journal of Molecular Medicine

Volumn 26, Issue 6, 2010, Pages 795-801

  Wang, Mingao ^a   Liu, Ruichan ^a   Jia, Xibei ^a   Mu, Suhong ^a   Xie, Rujuan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

smooth muscle actin; Monocyte chemoattractant protein 1; N acetyl seryl aspartyl lysyl proline; Nuclear factor B; Transforming growth factor 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; EOSIN; HEMATOXYLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; SERASPENIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATTENUATION; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INFUSION; DRUG INHIBITION; DRUG MECHANISM; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY PARENCHYMA; KIDNEY TUBULE EPITHELIUM; KIDNEY TUBULOINTERSTITIAL FIBROSIS; MACROPHAGE; MALE; MASSON STAIN; NEPHRITIS; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RECEPTOR UPREGULATION; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; URETER LIGATION; URETER OBSTRUCTION;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; FIBROSIS; HISTOCYTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY TUBULES; MACROPHAGES; MALE; NEPHRITIS; OLIGOPEPTIDES; RATS; RATS, WISTAR;

EID: 78649936776     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm-00000527     Document Type: Article

References (36)

1. Lenfant M, Wdzieczak-Bakala J, Guittet E, Prome JC, Sotty D and Frindel E: Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. Proc Natl Acad Sci USA 86: 779-782, 1989.
2. Rhaleb NE, Peng H, Harding P, Tayeh M, LaPointe MC and Carretero OA: Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts. Hypertension 37: 827-832, 2001. (Pubitemid 32221599)
3. Rhaleb NE, Peng H, Yang XP, Liu YH, Mehta D, Ezan E and Carretero OA: Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension. Circulation 103: 3136-3141, 2001. (Pubitemid 32587863)
4. Peng H, Carretero OA, Raij L, Yang F, Kapke A and Rhaleb NE: Antifibrotic effects of N-acetyl-seryl-aspartyl-Lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats. Hypertension 37: 794-800, 2001.
5. Sharma U, Rhaleb NE, Pokharel S, Harding P, Rasoul S, Peng H and Carretero OA: Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage. Am J Physiol Heart Circ Physiol 294: H1226-H1232, 2008.
6. Klahr S, Schreiner G and Ichikawa I: The progression of renal disease. N Engl J Med 318: 1657-1666, 1988.
7. Becker GJ and Hewitson TD: The role of tubulointerstitial injury in chronic renal failure. Curr Opin Nephrol Hypertens 9: 133-138, 2000. (Pubitemid 30131443)
8. Viedt C, Dechend R, Fei J, Hansch GM, Kreuzer J and Orth SR: MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-kappaB and activating protein-1. J Am Soc Nephrol 13: 1534-1547, 2002.
9. Tsuchiya K, Yoshimoto T, Hirono Y, Tateno T, Sugiyama T and Hirata Y: Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes. Am J Physiol Endocrinol Metab 291: E771-E778, 2006. (Pubitemid 44484919)
10. Iwano M, Plieth D, Danoff TM, Xue C, Okada H and Neilson EG: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350, 2002.
11. Lan HY: Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens 12: 25-29, 2003.
12. Liu Y: Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15: 1-12, 2004.
13. Kalluri R and Neilson EG: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784, 2003. (Pubitemid 38063698)
14. Yang J and Liu Y: Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159: 1465-1475, 2001. (Pubitemid 32947976)
15. Moochhala S, Chhatwal VJ, Chan ST, Ngoi SS, Chia YW and Rauff A: Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 17: 1171-1174, 1996.
16. Yang F, Yang XP, Liu YH, Xu J, Cingolani O, Rhaleb NE and Carretero OA: Ac-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction. Hypertension 43: 229-236, 2004. (Pubitemid 38174180)
17. Lin CX, Rhaleb NE, Yang XP, Liao TD, D'Ambrosio MA and Carretero OA: Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 295: H1253-H1261, 2008.
18. Shibuya K, Kanasaki K, Isono M, et al: N-acetyl-seryl-aspartyl-lysyl- proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db mice. Diabetes 54: 838-845, 2005.
19. Kuwabara N, Tamada S, Iwai T, et al: Attenuation of renal fibrosis by curcumin in rat obstructive nephropathy. Urology 67: 440-446, 2006.
20. Kitagawa K, Wada T, Furuichi K, et al: Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 165: 237-246, 2004.
21. Guijarro C and Egido J: Transcription factor-kappa B (NF-kappaB) and renal disease. Kidney Int 59: 415-424, 2001.
22. Gomez-Garre D, Largo R, Tejera N, Fortes J, Manzarbeitia F and Egido J: Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1. Hypertension 37: 1171-1178, 2001. (Pubitemid 32304021)
23. Hernandez-Presa M, Bustos C, Ortego M, Tunon J, Renedo G, Ruiz-Ortega M and Egido J: Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95: 1532-1541, 1997. (Pubitemid 27142812)
24. Ruiz-Ortega M, Bustos C, Hernandez-Presa MA, Lorenzo O, Plaza JJ and Egido J: Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol 161: 430-439, 1998.
25. Morrissey JJ and Klahr S: Rapid communication. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction. Kidney Int 52: 926-933, 1997.
26. Peng H, Carretero OA, Vuljaj N, Liao TD, Motivala A, Peterson EL and Rhaleb NE: Angiotensin-converting enzyme inhibitors: a new mechanism of action. Circulation 112: 2436-2445, 2005.
27. Peng H, Carretero OA, Liao TD, Peterson EL and Rhaleb NE: Role of N-acetyl-seryl-aspartyl-lysyl-proline in the antifibrotic and anti-inflammatory effects of the angiotensin-converting enzyme inhibitor captopril in hypertension. Hypertension 49: 695-703, 2007. (Pubitemid 46263215)
28. Cao Q, Mak KM and Lieber CS: Dilinoleoylphosphatidylcholine decreases LPS-induced TNF-alpha generation in Kupffer cells of ethanol-fed rats: respective roles of MAPKs and NF-kappaB. Biochem Biophys Res Commun 294: 849-853, 2002. (Pubitemid 34687194)
29. Border WA and Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 331: 1286-1292, 1994.
30. Sharma K and Ziyadeh FN: The transforming growth factor-beta system and the kidney. Semin Nephrol 13: 116-128, 1993.
31. Klahr S and Morrissey JJ: The role of growth factors, cytokines, and vasoactive compounds in obstructive nephropathy. Semin Nephrol 18: 622-632, 1998.
32. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC and Lan HY: Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56: 1455-1467, 1999.
33. Jinde K, Nikolic-Paterson DJ, Huang XR, Sakai H, Kurokawa K, Atkins RC and Lan HY: Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 38: 761-769, 2001. (Pubitemid 32927900)
34. Iwano M and Neilson EG: Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 13: 279-284, 2004.
35. Zeisberg M, Strutz F and Muller GA: Role of fibroblast activation in inducing interstitial fibrosis. J Nephrol 13: S111-S120, 2000.
36. El Chaar M, Chen J, Seshan SV, et al: Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction. Am J Physiol Renal Physiol 292: F1291-F1301, 2007.